Gene · 799
Papers3,617
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 3,617
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CircFAT1 Promotes Lung Adenocarcinoma Progression by Sequestering miR-7 from Repressing IRS2-ERK-mediated CCND1 Expression. | Int J Biol Sci | 2022 | 35844799 | PubTator, text mining | PubMed |
| Cooperative Binding of Substrate and Ions Drives Forward Cycling of the Human Creatine Transporter-1. | Front Physiol | 2022 | 35837012 | PubTator, text mining | PubMed |
| Molecular Dynamics Simulations and Diversity Selection by Extended Continuous Similarity Indices. | J Chem Inf Model | 2022 | 35834424 | PubTator, text mining | PubMed |
| The role of BAG3 in dilated cardiomyopathy and its association with Charcot-Marie-Tooth disease type 2. | Acta Myol | 2022 | 35832504 | PubTator, text mining | PubMed |
| Recent progress in Chinese fusion research based on superconducting tokamak configuration. | Innovation (Camb) | 2022 | 35815072 | PubTator, text mining | PubMed |
| Nrf2 Knockout Affected the Ferroptosis Signaling Pathway against Cisplatin-Induced Hair Cell-Like HEI-OC1 Cell Death. | Oxid Med Cell Longev | 2022 | 35814275 | PubTator, text mining | PubMed |
| Prognostic significance of PD-L1 expression and CD8+ TILs density for disease-free survival in surgically resected lung squamous cell carcinoma: a retrospective study. | J Thorac Dis | 2022 | 35813758 | PubTator, text mining | PubMed |
| First Identification of Rare Exonic and Deep Intronic Splice-Altering Variants in Patients With Beta-Sarcoglycanopathy. | Front Pediatr | 2022 | 35813381 | PubTator, text mining | PubMed |
| Profiling the 3D interaction between germ cell tumors and microenvironmental cells at the transcriptome and secretome level. | Mol Oncol | 2022 | 35811571 | PubTator, text mining | PubMed |
| Can Cisplatin Therapy Be Improved? Pathways That Can Be Targeted. | Int J Mol Sci | 2022 | 35806243 | PubTator, text mining | PubMed |
| As a Modulator, Multitasking Roles of SIRT1 in Respiratory Diseases. | Immune Netw | 2022 | 35799705 | PubTator, text mining | PubMed |
| TGFβ reprograms TNF stimulation of macrophages towards a non-canonical pathway driving inflammatory osteoclastogenesis. | Nat Commun | 2022 | 35798734 | PubTator, text mining | PubMed |
| Maintaining osteoclastogenesis following allogeneic hematopoietic stem cell transplantation for osteopetrosis: evidence from in vitro testing. | Haematologica | 2022 | 35796009 | PubTator, text mining | PubMed |
| p63 silencing induces epigenetic modulation to enhance human cardiac fibroblast to cardiomyocyte-like differentiation. | Sci Rep | 2022 | 35794145 | PubTator, text mining | PubMed |
| Physiological and Proteomic Analysis Responsive Mechanisms for Salt Stress in Oat. | Front Plant Sci | 2022 | 35783977 | PubTator, text mining | PubMed |
| Bone loss induced by cancer treatments in breast and prostate cancer patients. | Clin Transl Oncol | 2022 | 35779210 | PubTator, text mining | PubMed |
| Fibroblast growth factor signalling influences homologous recombination-mediated DNA damage repair to promote drug resistance in ovarian cancer. | Br J Cancer | 2022 | 35778553 | PubTator, text mining | PubMed |
| Advances in Our Understanding of the Mechanism of Action of Drugs (including Traditional Chinese Medicines) for the Intervention and Treatment of Osteoporosis. | Front Pharmacol | 2022 | 35774616 | PubTator, text mining | PubMed |
| Meaningful Improvement in General Health Outcomes with Guselkumab Treatment for Psoriatic Arthritis: Patient-Reported Outcomes Measurement Information System-29 Results from a Phase 3 Study. | Patient | 2022 | 35768650 | PubTator, text mining | PubMed |
| Curcumin Increased the Sensitivity of Non-Small-Cell Lung Cancer to Cisplatin through the Endoplasmic Reticulum Stress Pathway. | Evid Based Complement Alternat Med | 2022 | 35754693 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/799/papers?page=40